Patents by Inventor Christine Chable-Bessia

Christine Chable-Bessia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating retrovirus infections
    Patent number: 9439923
    Abstract: The present invention relates to at least one nucleic acid (i) comprising or consisting of or (ii) encoding a nucleic acid comprising or consisting of, a sequence selected from the group consisting of: 1) SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, and SEQ ID NO: 4, and 2) a sequence derived from SEQ ID NO: 1 to 4 by substitution deletion or insertion of at least one nucleotide, provided that a nucleic acid consisting of the sequence derived from SEQ ID NO: 1 to 4 is liable to induce HIV-1 expression in latent HIV-1-infected cells, for use as a medicament, in particular for treating retrovirus infections.
    Type: Grant
    Filed: November 26, 2009
    Date of Patent: September 13, 2016
    Assignee: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S)
    Inventors: Monsef Benkirane, Robinson Triboulet, Christine Chable-Bessia, Yamina Bennasser, Daniel Latreille, Oussama Meziane, Pascal Barbry, Bernard Mari, Jacques Reynes
  • COMPOSITIONS AND METHODS FOR TREATING RETROVIRUS INFECTIONS
    Publication number: 20120053223
    Abstract: The present invention relates to at least one nucleic acid (i) comprising or consisting of or (ii) encoding a nucleic acid comprising or consisting of, a sequence selected from the group consisting of: 1) SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, and SEQ ID NO: 4, and 2) a sequence derived from SEQ ID NO: 1 to 4 by substitution deletion or insertion of at least one nucleotide, provided that a nucleic acid consisting of the sequence derived from SEQ ID NO: 1 to 4 is liable to induce HIV-1 expression in latent HIV-1-infected cells, for use as a medicament, in particular for treating retrovirus infections.
    Type: Application
    Filed: November 26, 2009
    Publication date: March 1, 2012
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S)
    Inventors: Monsef Benkirane, Robinson Triboulet, Christine Chable-Bessia, Yamina Bennasser, Daniel Latreille, Oussama Meziane, Pascal Barbry, Bernard Mari, Jacques Reynes